JP2016531927A5 - - Google Patents

Download PDF

Info

Publication number
JP2016531927A5
JP2016531927A5 JP2016543278A JP2016543278A JP2016531927A5 JP 2016531927 A5 JP2016531927 A5 JP 2016531927A5 JP 2016543278 A JP2016543278 A JP 2016543278A JP 2016543278 A JP2016543278 A JP 2016543278A JP 2016531927 A5 JP2016531927 A5 JP 2016531927A5
Authority
JP
Japan
Prior art keywords
composition
cancer
ssrna
papmv
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016543278A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016531927A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2014/050908 external-priority patent/WO2015039255A1/en
Publication of JP2016531927A publication Critical patent/JP2016531927A/ja
Publication of JP2016531927A5 publication Critical patent/JP2016531927A5/ja
Pending legal-status Critical Current

Links

JP2016543278A 2013-09-19 2014-09-19 癌治療でのパパイヤモザイクウイルス及びウイルス様粒子 Pending JP2016531927A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361880156P 2013-09-19 2013-09-19
US61/880,156 2013-09-19
US201361886481P 2013-10-03 2013-10-03
US61/886,481 2013-10-03
PCT/CA2014/050908 WO2015039255A1 (en) 2013-09-19 2014-09-19 Papaya mosaic virus and virus-like particles in cancer therapy

Publications (2)

Publication Number Publication Date
JP2016531927A JP2016531927A (ja) 2016-10-13
JP2016531927A5 true JP2016531927A5 (https=) 2017-10-26

Family

ID=52688058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016543278A Pending JP2016531927A (ja) 2013-09-19 2014-09-19 癌治療でのパパイヤモザイクウイルス及びウイルス様粒子

Country Status (7)

Country Link
US (1) US20160228541A1 (https=)
EP (1) EP3046565A4 (https=)
JP (1) JP2016531927A (https=)
CN (1) CN105899217A (https=)
CA (1) CA2924819A1 (https=)
MX (1) MX2016003653A (https=)
WO (1) WO2015039255A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014059021A1 (en) 2012-10-09 2014-04-17 Case Western Reserve University Rod-shaped plant virus nanoparticles as imaging agent platforms
WO2014113203A1 (en) 2013-01-17 2014-07-24 Case Western Reserve University Viral nanoparticle multimers
US9925281B2 (en) 2014-08-05 2018-03-27 Case Western Reserve University Coated plant virus imaging agents
EP3215520B1 (en) 2014-11-07 2022-01-05 Case Western Reserve University Cancer immunotherapy using virus particles
EP3313527B1 (en) 2015-06-29 2021-02-24 Case Western Reserve University Anticancer drug-containing plant virus particles
EP3322485B1 (en) 2015-07-16 2020-07-01 Case Western Reserve University Plant virus particles for delivery of antimitotic agents
US12599141B2 (en) 2016-06-03 2026-04-14 Case Western Reserve University Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications
EP3487527A4 (en) 2016-07-21 2020-03-11 Case Western Reserve University Plant virus or virus-like particle constructs
US12433840B2 (en) 2016-11-03 2025-10-07 Case Western Reserve University Melt processed viral nanoparticle constructs
EP3535283A4 (en) 2016-11-03 2020-08-12 Case Western Reserve University CONSTRUCTIONS OF FUSION TREATED VIRAL NANOPARTICLES
US11590183B2 (en) 2017-03-10 2023-02-28 Case Western Reserve University Cancer immunotherapy using virus particles
WO2018213587A1 (en) 2017-05-17 2018-11-22 Case Western Reserve University Anticancer trail-targeted plant virus particles
US11739301B2 (en) 2017-10-27 2023-08-29 Case Western Reserve University Tymovirus virus and virus-like particles as nanocarriers for imaging and therapeutic agents
US11390853B2 (en) 2019-04-26 2022-07-19 Case Western Reserve University Freeze dried viral nanoparticle constructs
US11896676B2 (en) 2019-08-07 2024-02-13 Case Western Reserve University Targeting cancer cells and tissue using filamentous plant virus particles
US12203073B2 (en) 2019-12-20 2025-01-21 Case Western Reserve University Plant viral RNA delivery nanoparticles and uses thereof
US11529430B2 (en) 2019-12-20 2022-12-20 Case Western Reserve University Polydopamine decorated tobacco mosaic theranostic virus nanoparticles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101189B2 (en) * 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
ES2431963T3 (es) * 2002-07-05 2013-11-28 Folia Biotech Inc. Partícula viral adyuvante
US20140154288A1 (en) * 2011-05-13 2014-06-05 Folia Biotech Inc. Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response

Similar Documents

Publication Publication Date Title
JP2016531927A5 (https=)
Anestopoulos et al. Epigenetic therapy as a novel approach in hepatocellular carcinoma
MX2025014318A (es) Vector de adenovirus de chimpance util para la administracion de neoantigenos
PH12019501959A1 (en) Therapeutic rna
NZ732211A (en) Combination immunotherapy approach for treatment of cancer
MA39907A (fr) Nouvelle immunothérapie contre plusieurs tumeurs, du sang, notamment la leucémie aiguë myéloïde (lam)
EA201690016A1 (ru) Новый метод иммунотерапии нескольких видов опухолей, таких как рак легкого, включая нмрл
TW201613956A (en) Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
PH12017501728A1 (en) Chimeric antigen receptors targeting b-cell maturation antigen
PH12021551208A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
WO2015109180A3 (en) Compositions and methods for treatment and detection of cancers
JP2016538344A5 (https=)
PH12017500296B1 (en) Anti-tigit antibodies
PH12019500789A1 (en) Anti-c1s antibodies and methods of use thereof
TW201613648A (en) Compounds and compositions for immunotherapy
JP2013166763A5 (https=)
PH12022551095A1 (en) Humanized anti-c1s antibodies and methods of use thereof
WO2018083220A3 (en) Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines
EP3998341A3 (en) Adenoviral vectors
JP2018522880A5 (https=)
MX2019008105A (es) Virus.
SG10201806064XA (en) Anti-tumor compositions and methods
PH12016502008A1 (en) Novel immunotherapy against several tumors of the blood, such as acute myeloid lukemia (aml)
JP2015000064A5 (https=)
EP4461371A3 (en) Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers